---
title: 'Field Medical Director (MSL) – Ophthalmology (Southeast Region) at Annexon Biosciences'
canonical: 'https://feeny.ai/job/field-medical-director-msl-ophthalmology-southeast-region-annexon-biosciences-f7eyw4qqefam'
type: 'job'
last_seen: '2026-09-13'
---

# Field Medical Director (MSL) – Ophthalmology (Southeast Region) at Annexon Biosciences

- **Company:** Annexon Biosciences
- **Location:** San Francisco, CA
- **Posted:** 2026-07-24
- **Last confirmed live:** 2026-09-13
- **Apply:** https://job-boards.greenhouse.io/annexonbioscience/jobs/4718573005

## Job description

Company:

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.

For more information on Annexon and our pipeline, check out our site [Annexon Biosciences](https://annexonbio.com/) & [Annexon Pipeline](https://annexonbio.com/pipeline/). We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.

We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company [culture](https://annexonbio.com/our-culture/)!

Position:

The Field Medical Directors (FMDs) are medical experts who are an extension of the Medical Affairs team and represent Annexon with key stakeholders. They engage with national, regional, and local scientific, clinical, and social thought leaders (TLs) at academic and community medical centers as the scientific and medical expert on Annexon’s products and areas of research. This role will develop and maintain professional relationships with TLs based on scientific exchange of disease and Annexon product data.

Responsibilities include:

- Develop and maintain professional relationships with Thought Leaders (TLs) through compliant scientific exchange via two-way communication inclusive but not limited to pathogenesis of Therapeutic Areas (TA) of interest to Annexon, diagnosis, disease burden, treatment landscape, health economics, and relevant Annexon product data in line with medical affairs and Annexon strategy
- Collaborate with TLs on research projects, national and regional advisory boards, visiting professorships, publications, and peer-to-peer educational initiatives
- Develop and maintain the highest scientific and medical expertise in ophthalmologic disease, trials and treatment landscape with a patient centric mindset
- Identify potential high-impact medical research projects, investigator-initiated research, health-economic trials, and publication opportunities in line with Annexon TAs of interest
- Be acknowledged internally and externally as a trusted Scientific expert and build lasting professional relationships with TLs and Centers of Excellence & Research (COERs)
- Attend local, regional, national, international meetings and congresses as needed to engage in Scientific exchange, capture scientific insights, share data on Annexon products and TAs, and identify areas for collaboration with TLs
- Respond to healthcare professionals (HCPs) with integrity, a sense of urgency, adherence to all laws, regulations, and Annexon guidelines, policies & procedures
- Partner with Patient Advocacy Organizations in a compliant manner to integrate the patient voice into scientific and medical communications
- Deliver education on Annexon’s science and product data to P&T committees, formulary decision makers, and local, regional and national payers in accordance with all laws, regulations, and Annexon’s guidelines, policies, and procedures, while aligning with medical affairs and Annexon’s overall strategy
- Develop and execute tailored TL and HCP scientific engagement plans as needed
- Engage with TLs, trial investigators, and research staff, to support Clinical Development and Clinical Operations activities including but not restricted to identification of viable study sites, facilitation of participation in clinical trials, and patient recruitment
- Ensure strong, compliant collaboration with cross-functional field partners
- Serve as the Medical Expert and a field representative for Medical Directors with TLs, investigators, and other cross-functional partners

Education, Experience, and Skills:

Required:

- Scientific, healthcare or medical degree (PharmD, PhD, MD, DO)
- FMD requires 4 to 6 years of field-based experience in biopharmaceutical industry in medical affairs or relevant clinical roles and FMSD requires 6+ years of experience
- Prior experience as a Medical Science Liaison within Ophthalmology, with demonstrated expertise in retinal or ocular diseases and established relationships with key opinion leaders (KOLs) in the space.
- Scientific and patient-centric mindset with a successful track record of delivering results exceeding objectives in support of medical affairs and Annexon strategies
- Strong communication and presentation skills as evidenced by the ability to rapidly analyze complex scientific and medical data and synthesize for effective communication to audiences with diverse backgrounds
- Demonstrated ability to build scientific relationships with TLs, clinicians, researchers, and other relevant internal or external stakeholders
- Able to effectively collaborate within a matrix organization and cross functional teams
- Solid knowledge of the healthcare landscape inclusive but not limited to hospital systems, various points of care, and the roles of relevant HCPs in the target TAs
- Solid knowledge of the drug development process, and the role of various internal and external stakeholders in various phases of R&D
- Able to document insights, TL engagement and complete all administrative tasks in a timely fashion
- Capable of working independently to prioritize tasks, develop and implement action plans, and make sound, compliant decisions
- Strong understanding of compliance, and the legal and regulatory landscape as they relate to HCP interactions
- Flexible to travel within assigned region based on business needs and occasionally nationally or internationally

Location: Southeast Region / Remote Field Based (includes onsite travel to Annexon – HQ)

Level: This role may be filled at the Associate Director or Director level, depending on the candidate’s experience and qualifications

Salary Range: $190,000 - $224,000

Benefits:

- A stimulating and rewarding workplace includes flexible work schedules, remote opportunities and the ability to achieve a work-life balance.
- Shuttle service from BART, CalTrain and the Ferry.
- Annexon offers a competitive base salary and equity participation, employee stock purchase plan, as well as a comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, and other benefits.

Annexon Biosciences is an Equal Opportunity Employer, and we prohibit discrimination or harassment of any kind.  We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths, views, and experiences. We believe that our differences enable us to be a better team – one that makes better decisions, drives innovation, and delivers better business results. Creativity and innovation flourish in an environment of openness, inclusion, and mutual respect.

## About Annexon Biosciences

## Company Overview
- **One-liner**: Annexon Biosciences is a clinical-stage biopharmaceutical company pioneering the development of C1q inhibitors to stop classical complement-mediated neuroinflammation in autoimmune, neurodegenerative, and ophthalmic diseases.
- **Entity Type**: Public (Nasdaq: ANNX)
- **Headquarters**: Brisbane, California, USA
- **Founded**: 2007
- **Founders**: Dr. Ben Barres (co‑founder, deceased) and Dr. Arnon Rosenthal

## Core Business
- **Industry**: Biopharmaceuticals – complement‑targeted therapeutics
- **Target Customers**: Patients and healthcare providers treating classical complement‑mediated diseases (body, brain, eye); B2B partnerships with clinical sites and payers
- **Mission**: “Deliver game‑changing therapies to patients so that they can live their best lives” [annexonbio.com](https://annexonbio.com/about/)

## Products & Services
Annexon’s pipeline is based on inhibiting C1q, the initiating molecule of the classical complement pathway. Key investigational candidates:
- **ANX005**: A monoclonal antibody targeting C1q for intravenous administration. Lead indication is Guillain‑Barré Syndrome (GBS); completed enrollment in a Phase 3 pivotal program – the first such program in GBS in 40 years – and has Orphan Drug Designation from the EMA [annexonbio.com](https://annexonbio.com/about/)
- **ANX007**: An intravitreal antibody fragment targeting C1q for ophthalmic use. Demonstrated statistically significant, dose‑dependent preservation of visual function in a Phase 2 trial in geographic atrophy (GA) [annexonbio.com](https://annexonbio.com/about/)
- **ANX009**: A subcutaneous formulation of ANX005 designed for chronic autoimmune and neurodegenerative indications. Achieved full target engagement in the blood compartment in a Phase 1 healthy volunteer study [annexonbio.com](https://annexonbio.com/about/)
- **ANX1502**: An oral small‑molecule inhibitor of the classical complement pathway. Achieved target pharmacokinetics in a Phase 1 healthy volunteer study [annexonbio.com](https://annexonbio.com/about/)

## Market Standing
- **Valuation / Market Cap**: Not publicly available from provided sources (public company, market cap fluctuates)
- **Key Metric**: Publicly traded (Nasdaq: ANNX); recent major milestones include Phase 3 completion for ANX005 in GBS and Phase 2 data for ANX007 in GA
- **Notable Investors / Partners**: Leaders on board and scientific advisory board include Stephen Hauser (MD, UCSF), Beth Stevens (PhD, Harvard), David Holtzman (MD, Washington University), and others. The co‑founder Dr. Ben Barres was a highly respected neuroscientist [annexonbio.com](https://annexonbio.com/about/)
- **Growth Signals**: Initial public offering in 2020 funded pipeline expansion; active recruiting for senior clinical and medical affairs roles (Senior Director, Clinical Development; VP, Drug Safety; etc.) suggests advancement toward late‑stage trials and potential commercialization [greenhouse.io](https://job-boards.greenhouse.io/annexonbioscience)

## Competitive Advantages
- **First‑in‑class C1q inhibitor focus**: By targeting the top of the classical complement pathway, Annexon aims to block all downstream damaging components rather than a single downstream effector.
- **Broad pipeline across three therapeutic areas** (autoimmunity, neurodegeneration, ophthalmology) targeting nearly 10 million patients worldwide.
- **Biomarker‑driven, disciplined strategy** to improve probability of technical success and deliver precision medicine [ir.annexonbio.com](https://ir.annexonbio.com/corporate-profile)
- **Strong scientific foundation** built on decades of research by co‑founder Dr. Ben Barres on C1q’s role in synapse loss.

## Strategic Focus
- Completing the first Phase 3 program for GBS in 40 years (ANX005) and preparing for regulatory submissions.
- Advancing ANX007 through pivotal trials for geographic atrophy and exploring glaucoma.
- Developing subcutaneous and oral formulations (ANX009, ANX1502) to expand into chronic, less invasive treatment paradigms.
- Employing precision‑medicine biomarkers to identify patients most likely to benefit from classical complement inhibition.

## Why Work Here
- **Culture**: Described as “show up with your heart and mind … team‑based, follow the science.” Core values include warrior spirit, all‑for‑one teamwork, sound judgment, passion, and a thrive mentality [annexonbio.com/careers](https://annexonbio.com/careers/)
- **Work Environment**: Flexible work schedules, remote opportunities, and a Brisbane, CA office with shuttle service from BART, CalTrain, and the Ferry [annexonbio.com/careers](https://annexonbio.com/careers/)
- **Benefits**: Competitive base salary, equity participation, employee stock purchase plan (ESPP), medical/dental/vision insurance, 401(k), flexible spending plans, and a focus on work‑life balance [annexonbio.com/careers](https://annexonbio.com/careers/)
- **Team**: About 4 open positions as of mid‑2026 (Senior Director Clinical Development, VP Drug Safety, etc.) – a small, driven team where contributions are visible and valued [greenhouse.io](https://job-boards.greenhouse.io/annexonbioscience)

## Sources
1. [annexonbio.com – Home](https://annexonbio.com/)
2. [ir.annexonbio.com – Corporate Profile](https://ir.annexonbio.com/corporate-profile)
3. [annexonbio.com – About (Leadership, History, Mission)](https://annexonbio.com/about/)
4. [annexonbio.com – Careers (Culture, Benefits, Values)](https://annexonbio.com/careers/)
5. [greenhouse.io – Jobs at Annexon Biosciences](https://job-boards.greenhouse.io/annexonbioscience)

## Other roles at Annexon Biosciences

- [Senior Director, Global Scientific Communications](https://feeny.ai/job/senior-director-global-scientific-communications-annexon-biosciences-san-ygq0cdyxzd03) — San Francisco, CA
- [Executive Director & Head Clinical Data Management](https://feeny.ai/job/executive-director-head-clinical-data-management-annexon-biosciences-san-srwq0ehec0wz) — San Francisco, CA
- [Senior Director, Regulatory Affairs](https://feeny.ai/job/senior-director-regulatory-affairs-annexon-biosciences-san-francisco-b2av8f6dqd9f) — San Francisco, CA
- [Senior Director, Medical Writing](https://feeny.ai/job/senior-director-medical-writing-annexon-biosciences-san-francisco-kxv9t4ghnxry) — San Francisco, CA
- [Associate Director, Clinical Trial Management](https://feeny.ai/job/associate-director-clinical-trial-management-annexon-biosciences-san-francisco-h3rh38k6a3ek) — San Francisco, CA
- [Senior Director, Drug Safety and Pharmacovigilance](https://feeny.ai/job/senior-director-drug-safety-and-pharmacovigilance-annexon-biosciences-san-w7jhxhsm0t09) — San Francisco, CA
- [Vice President, Medical Affairs-Neuroscience](https://feeny.ai/job/vice-president-medical-affairs-neuroscience-annexon-biosciences-san-francisco-vec8c090165d) — San Francisco, CA
- [Vice President, Clinical Development-Ophthalmology](https://feeny.ai/job/vice-president-clinical-development-ophthalmology-annexon-biosciences-san-8j8gnj3vpggn) — San Francisco, CA
- [Vice President, Medical Affairs-Ophthalmology](https://feeny.ai/job/vice-president-medical-affairs-ophthalmology-annexon-biosciences-san-francisco-4k8s7zf170d6) — San Francisco, CA